If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
Funds Will Support Global Commercialization of the Synchrony(R) Dual Optic Accommodating Intraocular Lens IRVINE, Calif.–(HSMN NewsFeed)–Visiogen, Inc. of Irvine, California, announces that it has raised $40 million from new and current investors to s…
Devices, Ophthalmology, Venture Capital
Visiogen, Dual Optic, Accommodating Intraocular Lens, Intraocular Lens
Posts from ‘April, 2009’
Visiogen Secures $40 Million in Equity Financing
Ligand Announces Approval in Europe of CONBRIZA for Treatment of Postmenopausal Osteoporosis in Women at Increased Risk of Fracture
Earns Milestone Payment from Wyeth SAN DIEGO–(HSMN NewsFeed)–Ligand Pharmaceuticals Incorporated (NASDAQ:LGND ) today announced that its partner Wyeth (NYSE:WYE ) has received approval from the European Commission (EC) for CONBRIZA(TM) (bazedoxifene),…
Biopharmaceuticals, Regulatory
Ligand Pharmaceuticals, Wyeth, CONBRIZA, bazedoxifene, osteoporosis
Human Genome Sciences Reports Positive Late-Breaker Results at EASL from ACHIEVE Phase 3 Trials of Albuferon(R) in Patients with Chronic Hepatitis C
With half as many injections, in 2 pivotal Phase 3 trials, Albuferon (albinterferon alfa-2b) met the primary efficacy endpoint of sustained virologic response comparable to Pegasys (peginterferon alfa-2a) Patients receiving 900-mcg Albuferon had compa…
Biopharmaceuticals
Human Genome Sciences, hepatitis C , Albuferon, albinterferon alfa-2b
Varian Medical Systems to Exhibit Full Spectrum of Prostate Cancer Treatment Technologies at the American Urological Association Meeting in Chicago
Company will showcase technologies for brachytherapy, intensity-modulated radiotherapy (IMRT), RapidArc(TM) radiotherapy, and stereotactic body radiotherapy (SBRT) PALO ALTO, Calif., April 24 (HSMN NewsFeed) — Varian Clinical Systems (NYSE: VAR ) will…
Devices, Oncology, Urology
Varian Clinical Systems, brachytherapy, RapidArc, radiotherapy
New National Survey Shows That Overactive Bladder Symptoms Are Pervasive and Difficult to Manage
Data Show that Among Middle-Aged Women, Overactive Bladder Symptoms Have a Ripple Effect on Lifestyle CHICAGO–(HSMN NewsFeed)–Results from a nationwide survey of women ages Forty to 65 show that the symptoms of overactive bladder (OAB) are compromising t…
Devices, Urology
Medtronic, overactive bladder, InterStim Therapy
An Independent Study Reports on the Utility of ImmuKnow(R), the Cylex(TM) Immune Cell Function Assay, for Monitoring Heart Transplant Recipients
The results of the largest study performed to date will be presented during the International Society for Heart and Lung Transplantation Annual Meeting in Paris, France on April 24, 2009 COLUMBIA, Maryland, April 24 (HSMN NewsFeed) — Since it was cle…
Diagnostics, Cardiology
Cylex, ImmuKnow, adenosine triphosphate, heart transplant
SIMPONI(TM) (golimumab) Receives FDA Approval as First Once-Monthly Anti-TNF for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
First Subcutaneous Anti-TNF to Launch with Three Rheumatic Indications Simultaneously and with Novel SmartJect(TM) Autoinjector HORSHAM, Pa., April 24 (HSMN NewsFeed) — Centocor Ortho Biotech Inc. announced today that the U.S. Food and Drug Administr…
Biopharmaceuticals, FDA
Centocor Ortho Biotech, SIMPONI, golimumab, rheumatoid arthritis
BK Pharmaceutical to Introduce Flex Focus Mobile Ultrasound Scanner at American Urological Association Annual Meeting in Chicago
Flex Focus - Mobile Ultrasound Has Grown Up COPENHAGEN, Denmark–(HSMN NewsFeed)–BK Pharma, a wholly owned subsidiary of Analogic Corporation (NASDAQ:ALOG ), today announced the American-market premiere of the Flex Focus ultrasound scanner at the Amer…
Devices, Urology
BK Medical, Analogic Corp, Flex Focus, ultrasound
Roche Announces Collaboration to Investigate New Treatment Strategy With Tarceva in Lung Cancer
New Phase III Study Will Evaluate if Tarceva is Superior to Traditional Chemotherapy in First Line Treatment of key Group of Patients BASEL, Switzerland, April 24 (HSMN NewsFeed) - Roche and the Spanish Lung Cancer Group (SLCG) today announced their co…
Biopharmaceuticals, Oncology
Roche Group, Tarceva, erlotinib, lung cancer, EURTAC trial
St. Jude Laboratory Announces CE Mark Approval of Remote Care System for Implantable Cardiac Devices
Cutting-edge Web-based system, Merlin.net Patient Care Network (PCN), combines tools that can help physicians monitor patients and improve clinic efficiency ST. PAUL, Minn.–(HSMN NewsFeed)–St. Jude Clinical, Inc. (NYSE:STJ ) today announced European CE…
Devices, Cardiology, Regulatory
St. Jude Clinical, Merlin.net, Patient Care Network
